EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Endothelial VEGFR2-PLCγ signaling regulates vascular permeability and antitumor immunity through eNOS/Src

Elin Sjöberg, Marit Melssen, Mark Richards, Yindi Ding, Catarina Chanoca, Dongying Chen, Emmanuel Nwadozi, Sagnik Pal, Dominic T Love, Takeshi Ninchoji, Masabumi Shibuya, Michael Simons und 2 weitere

Journal of Clinical Investigation · 16.10.2023 · 133 (20)

DOI: 10.1172/jci161366 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Clinical Investigation, online erschienen am 16.10.2023. Verfasst von Elin Sjöberg und 13 weiteren Autor:innen. Beteiligte Einrichtung: Department of Immunology, Genetics and Pathology, Beijer and Science for Life Laboratories, Uppsala University, Uppsala, Sweden. Hauptthemen laut MEDLINE: Capillary Permeability, Carcinoma, Renal Cell, Kidney Neoplasms. Die Arbeit wurde bisher 60-mal zitiert (Crossref) und nennt 71 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NHLBI NIH HHS, Swedish Research Council, Knut and Alice Wallenberg foundation.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Capillary PermeabilityCarcinoma, Renal CellKidney NeoplasmsAnimalsHumansMiceNitric Oxide Synthase Type IIIPhospholipase C gammaPhosphorylationVascular Endothelial Growth Factor AVascular Endothelial Growth Factor Receptor-2CSK Tyrosine-Protein Kinase

Stichwörter der Autor:innen

OncologySignal transductionVascular Biology

Substanzen

Nitric Oxide Synthase Type IIIPhospholipase C gammaVascular Endothelial Growth Factor AVascular Endothelial Growth Factor Receptor-2CSK Tyrosine-Protein Kinase

Autor:innen und Institutionen

  • Department of Immunology, Genetics and Pathology, Beijer and Science for Life Laboratories, Uppsala University, Uppsala, Sweden.
  • Yale Cardiovascular Research Center, Department of Internal Medicine, Yale University School of Medicine, New Haven, Connecticut, USA.
  • Institute of Physiology and Medicine, Jobu University, Takasaki, Gunma, Japan.
  • Department of Cell Biology, Yale University School of Medicine, New Haven, Connecticut, USA.

Förderung

  • NHLBI NIH HHS
  • Swedish Research Council
  • Knut and Alice Wallenberg foundation
  • Fondation Leducq Transatlantic Network of Excellence Grant in Neurovascular Disease
  • NIH
  • Swedish Childhood Cancer Fund
  • Swedish Cancer Society
  • Swedish Society for Medical Research

Zitieren

APA

Sjöberg, E., Melssen, M., Richards, M., Ding, Y., Chanoca, C., Chen, D., Nwadozi, E., Pal, S., Love, D. T., Ninchoji, T., Shibuya, M., Simons, M., Dimberg, A., & Claesson-Welsh, L. (2023). Endothelial VEGFR2-PLCγ signaling regulates vascular permeability and antitumor immunity through eNOS/Src. Journal of Clinical Investigation, 133(20). https://doi.org/10.1172/jci161366

Vancouver

Sjöberg E, Melssen M, Richards M, Ding Y, Chanoca C, Chen D, et al. Endothelial VEGFR2-PLCγ signaling regulates vascular permeability and antitumor immunity through eNOS/Src. Journal of Clinical Investigation. 2023;133(20). doi:10.1172/jci161366

BibTeX
@article{Sjberg2023,
  author = {Sjöberg, Elin and Melssen, Marit and Richards, Mark and Ding, Yindi and Chanoca, Catarina and Chen, Dongying and Nwadozi, Emmanuel and Pal, Sagnik and Love, Dominic T and Ninchoji, Takeshi and Shibuya, Masabumi and Simons, Michael and Dimberg, Anna and Claesson-Welsh, Lena},
  title = {Endothelial VEGFR2-PLCγ signaling regulates vascular permeability and antitumor immunity through eNOS/Src},
  journal = {Journal of Clinical Investigation},
  year = {2023},
  volume = {133},
  number = {20},
  doi = {10.1172/jci161366}
}
Kostenlos starten →